Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2014
03/12/2014CN102871985B Hemoglobin microcapsule blood substitute and its preparation method
03/12/2014CN102824304B Cefepime hydrochloride composition for injection and its preparation method
03/12/2014CN102793927B Swine fever vaccine heat-resistant freeze-drying protective agent, and preparation method and application thereof
03/12/2014CN102764281B Ointment for treating condyloma acuminatum and preparation method thereof
03/12/2014CN102762205B Coated solid preparation
03/12/2014CN102755302B Delayed release preparation containing safe and reliable plasticizer and preparation method thereof
03/12/2014CN102731632B Recombinant ganoderma immunomodulatory protein monomethoxypolyglycol succinimidyl propionate modifier, preparation method and use thereof
03/12/2014CN102657598B Porous inorganic material based oral preparation of secondary-dispersion insoluble drug and preparation method thereof
03/12/2014CN102579367B Topiramate sustained-release drug composition, method for preparing same and application of Topiramate sustained-release drug composition
03/12/2014CN102525876B Aspirin solid dispersion, as well as preparation method, pharmaceutical composition and use thereof
03/12/2014CN102516696B Method for preparing bioluminescent nano thermometer
03/12/2014CN102512378B Stable and safe oxiracetam pharmaceutical composition for injection
03/12/2014CN102488970B Electromagnetic therapeutic apparatus
03/12/2014CN102316860B Film base for adhesive patch, and adhesive patch
03/12/2014CN102302456B Preparation method of tilmicosin phosphate microsphere specifically for use on animals
03/12/2014CN102210648B High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
03/12/2014CN102202694B Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to same
03/12/2014CN102143761B Agent for treating myelofibrosis
03/12/2014CN102018658B Controlled release preparation and preparation method thereof
03/12/2014CN101927002B Medicament and coating composition
03/12/2014CN101880381B Segmented copolymer modified by polyethylene glycol 1000 vitamin E succinic acid ester, preparation method and applications thereof
03/12/2014CN101642426B Baicalin adhesion type nanometer eye drops and preparation method thereof
03/11/2014US8669290 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
03/11/2014US8669270 SNS-595 and methods of using the same
03/11/2014US8669237 Biodegradable immunomodulatory formulations and methods for use thereof
03/11/2014US8669231 Activation of peptide prodrugs by hK2
03/11/2014US8668898 Low radiocarbon dietary supplements and foods and methods of making and using same
03/11/2014CA2748620C Naltrexone hydrochloride compositions
03/11/2014CA2672971C Stabilized sulforaphane
03/11/2014CA2648280C Controlled release delivery device comprising an organosol coat
03/11/2014CA2631821C Pre-compacted calcium-containing compositions
03/11/2014CA2573000C Composition containing statins and omega-3 fatty acids
03/11/2014CA2572106C Low temperature drying methods for forming drug-containing polymeric compositions
03/11/2014CA2567449C Antibodies and related molecules that bind to psca proteins
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/11/2014CA2486127C Method of treating dyslipidemic disorders
03/11/2014CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
03/11/2014CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/10/2014CA2826708A1 Excipient system for topical delivery of pharmaceutical agents
03/06/2014WO2014036566A1 Clickable polyoxetane carrier for drug delivery
03/06/2014WO2014036492A1 Modified amino acids comprising an azido group
03/06/2014WO2014036210A1 Foot implant and method for treating plantar fasciitis
03/06/2014WO2014036194A1 Polymeric nanocarriers with light-triggered release mechanism
03/06/2014WO2014035839A2 Compositions and methods for treating hepatocellular cancer
03/06/2014WO2014035798A1 Silk lyogels for sustained release of protein therapeutics and methods of making and uses
03/06/2014WO2014035465A1 The controlled release method for a pharmaceutical composition composed of chelating complex micelles
03/06/2014WO2014035451A1 Ophthalmic compositions with wax esters
03/06/2014WO2014035450A1 Ophthalmic compositions with omega-3 fatty acids
03/06/2014WO2014035219A1 Dosage form for oral administration capable of being adhered to flowing gastric mucosa
03/06/2014WO2014034939A1 Adhesive skin patch
03/06/2014WO2014034929A1 Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
03/06/2014WO2014034902A1 Amine salt and crystals thereof
03/06/2014WO2014034884A1 Cryopreservable cell scaffold material
03/06/2014WO2014034860A1 Orally administered medical composition
03/06/2014WO2014034669A1 Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
03/06/2014WO2014034548A1 Method for producing seamless capsule
03/06/2014WO2014034046A1 Vaccine formulation against toxoplasma gondii infection
03/06/2014WO2014033744A2 A novel pharmaceutical composition of linezolid
03/06/2014WO2014033680A1 Gelling formulation containing ketamine
03/06/2014WO2014033441A1 Fusion proteins and methods for treating, preventing or ameliorating pain
03/06/2014WO2014033184A1 Use of a vegf antagonist in treating ocular vascular proliferative diseases
03/06/2014WO2014032780A1 Hybrid hydrogels
03/06/2014WO2014032676A1 A solid oral formulation for treatment and/or prevention of overweight and/or for stabilizing blood sugar levels in an individual.
03/06/2014WO2014032176A1 Methods for the treatment of hepatitis b and hepatitis d infections
03/06/2014WO2014032099A1 Composition and method for bone growth
03/06/2014WO2014011083A3 Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same
03/06/2014WO2014003850A3 Methods for treatment of ocular diseases
03/06/2014WO2013160773A3 Polymeric nanoparticles and process of preparation thereof
03/06/2014US20140066694 Immobilized bioactive hydrogel matrices as surface coatings
03/06/2014US20140066592 Methods and compositions for the treatment of cancer or other diseases
03/06/2014US20140066577 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same
03/06/2014US20140066524 Compositions, gels and foams with rheology modulators and uses thereof
03/06/2014US20140066523 Drug Delivery Compositions And Methods Of Use
03/06/2014US20140066522 Emulsions of perfluorocarbons
03/06/2014US20140066516 Novel Method
03/06/2014US20140066511 Topical delivery of l-arginine to cause beneficial effects
03/06/2014US20140066507 Cosmetic compositions comprising epa and salicylic acid and methods of making and using same
03/06/2014US20140066505 Utilization of Dialkylfumarates
03/06/2014US20140066481 Water-Free Pharmaceutical Compositions Suitable for Local Anaesthetics
03/06/2014US20140066471 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
03/06/2014US20140066452 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
03/06/2014US20140066447 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
03/06/2014US20140066440 Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
03/06/2014US20140066437 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
03/06/2014US20140066417 Anaesthetic formulation
03/06/2014US20140066411 Pharmaceutical compositions for extended release of azo-bonded 5-aminosalicylic acid compositions
03/06/2014US20140066389 Method and pharmaceutical to treat spinal discs
03/06/2014US20140066388 Mitochondrial-targeted cationic nanoparticles comprising camkii inhibitors and uses thereof for treating and preventing diseases and disorders associated with camkii activity
03/06/2014US20140066371 Methods for administering long-lasting hypoglycemic agents
03/06/2014US20140066364 Cyanoacrylate tissue adhesives
03/06/2014US20140065425 Graft-copolymer stabilized metal nanoparticles
03/06/2014US20140065234 Polymersomes, liposomes, and other species associated with fluidic droplets
03/06/2014US20140065233 Injectable microspheres for dermal augmentation and tissue bulking
03/06/2014US20140065226 Thermo-responsive hydrogel compositions
03/06/2014US20140065221 Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material
03/06/2014US20140065220 Binder for forming tablets
03/06/2014US20140065205 Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
03/06/2014US20140065204 Compositions and methods for delivering nucleic acid to a cell
03/06/2014US20140065192 Sour gelled emulsions
03/06/2014US20140065156 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 1712